LifeScan Diabetes Deal Brings $2.1 Billion
Johnson & Johnson’s (NYSE: JNJ) selling spree continued with the divestiture of LifeScan, Inc. for $2.1 billion. LifeScan is a leader in blood glucose monitoring products, serving approximately 20 million patients globally in more than 90 countries. LifeScan markets blood glucose monitoring systems for home and hospital use under the global brand, One Touch. The OneTouch portfolio includes personal blood glucose meters, testing strips, lancets, point of care testing systems and integrated digital solutions. The buyer, Platinum Equity, made its offer in March 2018 after working with J&J to craft a deal to allow LifeScan to beome a standalone business that would continue to... Read More »Medical Imaging Deals Abound
Only half way through October, we’ve seen three transactions targeting a medical imaging company in our Laboratories, MRI & Dialysis sector. That brings to 10 the number of imaging targets in 2015, out of the current total of 39 deals recorded in the sector. It began on October 1, with Konica Minolta Medical Imaging USA’s announcement that it was buying Viztek, LLC, a digital software and hardware imaging company, for an undisclosed price. Another optical giant, Toshiba Medical Systems Corporation, announced its acquisition of Olea Medical SA, a French medical imaging applications company, for an undisclosed price. The next day, Digirad Corporation (NASDAQ: DRAD) paid $36... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
